SCNI - Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023 | Benzinga
JERUSALEM, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) today announced that it will be showcasing its CDMO services at CPHI Barcelona, one of the international pharmaceutical industry's premier trade shows, taking place October 24 to 26.
Several members of Scinai's executive leadership team will be available to meet with potential partners and clients of the company's end-to-end biologics CDMO service. Scinai's booth is located in Hall 8.1, Booth 11.
One-to-one meetings may be requested through the CPHI partnering platform, accessible to participants after registration at europe.cphi.com. Interested parties are also welcome to email Scinai directly at CDMO@scinai.com.
Scinai's CDMO offers upstream and downstream process development and scale-up for protein-based drugs, analytical method development, and cGMP manufacturing including aseptic filling to biopharmaceutical and biotech clients.
In addition to CPHI Barcelona, Scinai will be attending BIO-Europe in Munich, Germany (November 6-8), and MIXiii Health-Tech.IL in Jerusalem, Israel (November 7-8). Details are listed on Scinai's new website at www.scinai.com/events.
About Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) is a biopharmaceutical ...